Citadel Advisors’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-1,466
| Closed | -$10K | – | 7181 |
|
|
2022
Q3 | $10K | Sell |
1,466
-1,328
| -48% | -$9.06K | ﹤0.01% | 5654 |
|
|
2022
Q2 | $30K | Buy |
+2,794
| New | +$30K | ﹤0.01% | 5634 |
|
|
2022
Q1 | – | Sell |
-559
| Closed | -$16K | – | 7523 |
|
|
2021
Q4 | $16K | Sell |
559
-2,048
| -79% | -$58.6K | ﹤0.01% | 6335 |
|
|
2021
Q3 | $170K | Buy |
2,607
+65
| +3% | +$4.24K | ﹤0.01% | 5532 |
|
|
2021
Q2 | $203K | Buy |
+2,542
| New | +$203K | ﹤0.01% | 5571 |
|
|
2020
Q2 | – | Sell |
-391
| Closed | -$31K | – | 5504 |
|
|
2020
Q1 | $31K | Buy |
+391
| New | +$31K | ﹤0.01% | 4610 |
|